• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form S-8 POS filed by Hill-Rom Holdings Inc

    12/13/21 5:01:05 PM ET
    $HRC
    Medical/Dental Instruments
    Health Care
    Get the next $HRC alert in real time by email
    S-8 POS 1 d446474ds8pos.htm S-8 POS S-8 POS

    As filed with the Securities and Exchange Commission on December 13, 2021

    Registration Nos. 333-88328

    333-157341

    333-157338

    333-254169

     

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    WASHINGTON, D.C. 20549

     

     

    FORM S-8

    POST-EFFECTIVE AMENDMENT NO. 1 TO:

    Form S-8 Registration Statement No. 333-88328

    Form S-8 Registration Statement No. 333-157341

    Form S-8 Registration Statement No. 333-157338

    Form S-8 Registration Statement No. 333-254169

    UNDER

    THE SECURITIES ACT OF 1933

     

     

    HILL-ROM HOLDINGS, INC.

    (Exact name of registrant as specified in its charter)

     

     

     

    Indiana

    (State or other jurisdiction of

    incorporation or organization)

     

    35-1160484

    (I.R.S. Employer

    Identification No.)

    130 E. Randolph St. Suite 1000

    Chicago, IL

    (Address of Principal Executive Offices)

     

    60601

    (Zip Code)

    Hillenbrand Industries, Inc. Board of Directors’ Deferred Compensation Plan

    Hill-Rom Holdings, Inc. Stock Incentive Plan

    Hill-Rom Holdings, Inc. Employee Stock Purchase Plan

    Hill-Rom Holdings, Inc. 2021 Stock Incentive Plan

    (Full Title of Plans)

    Ellen K. Bradford

    Vice President and Secretary

    130 E. Randolph St. Suite 1000

    Chicago, IL 60601

    (Name and address of agent for service)

    (312) 819-7200

    (Telephone number, including area code, of agent for service)

     

     

    Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer”, “smaller reporting company”, and “emerging growth company” in Rule 12b-2 of the Exchange Act.

     

    Large accelerated filer   ☒    Accelerated filer   ☐
    Non-accelerated filer   ☐    Small reporting company   ☐
         Emerging growth company   ☐

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act.  ☐

     

     

     


    EXPLANATORY NOTE

    This Post-Effective Amendment No. 1 to each of the following Registration Statements on Form S-8 (collectively, the “Prior Registration Statements”) is being filed by Hill-Rom Holdings, Inc. (the “Registrant” or “Hill-Rom”) to terminate all offerings under the Prior Registration Statements and to deregister any and all shares of Hill-Rom common stock, without par value (the “Shares”), together with any and all plan interests and other securities registered but unsold as of the date hereof thereunder (note that the Share numbers listed below do not take into account any applicable corporate actions, such as stock splits, that may have been taken in the interim):

     

      1.

    Registration Statement on Form S-8, File No. 333-88328, filed with the Securities and Exchange Commission (the “Commission”) on May 15, 2002, registering 50,000 Shares pursuant to the Hillenbrand Industries, Inc. Board of Directors’ Deferred Compensation Plan.

     

      2.

    Registration Statement on Form S-8, File No. 333-157341, filed with the Commission on February 13, 2009, registering 5,500,000 Shares pursuant to the Hill-Rom Holdings, Inc. Stock Incentive Plan.

     

      3.

    Registration Statement on Form S-8, File No. 333-157338, filed with the Commission on February 13, 2009, registering 1,000,000 Shares pursuant to the Hill-Rom Holdings, Inc. Employee Stock Purchase Plan.

     

      4.

    Registration Statement on Form S-8, File No. 333-254169, filed with the Commission on March 11, 2021, registering the offer and sale of 3,000,000 Shares issuable pursuant to the Hill-Rom Holdings, Inc. 2021 Stock Incentive Plan.

    On September 1, 2021, the Registrant entered into an Agreement and Plan of Merger (the “Merger Agreement”) with Baxter International Inc., a Delaware corporation (“Baxter”), and Bel Air Subsidiary, Inc., an Indiana corporation and wholly-owned subsidiary of Baxter (“Merger Sub”). On December 13, 2021, pursuant to the terms of the Merger Agreement, Merger Sub merged with and into the Registrant (the “Merger”), with the Registrant surviving the Merger as a wholly owned subsidiary of Baxter.

    In connection with the Merger, the Registrant has terminated all offerings of the Registrant’s securities pursuant to the Prior Registration Statements. Accordingly, pursuant to the undertakings made by the Registrant in the Prior Registration Statements to remove from registration, by means of a post-effective amendment, any of the securities that remain unsold at the termination of the offerings, this Post-Effective Amendment No. 1 hereby removes from registration all of such securities registered under the Prior Registration Statements that remain unsold as of the date of this Post-Effective Amendment No. 1.


    SIGNATURES

    Pursuant to the requirements of the Securities Act of 1933, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Post-Effective Amendment No. 1 to the Prior Registration Statements to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Deerfield, State of Illinois, on December 13, 2021.

     

    HILL-ROM HOLDINGS, INC.

    By:  

    /s/ Ellen K. Bradford

      Name: Ellen K. Bradford
      Title: Vice President and Secretary

    No other person is required to sign this Post-Effective Amendment No. 1 to the Prior Registration Statements in reliance upon Rule 478 under the Securities Act of 1933, as amended.

    Get the next $HRC alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $HRC

    DatePrice TargetRatingAnalyst
    9/20/2021$148.00 → $156.00Overweight → Equal-Weight
    Morgan Stanley
    9/8/2021Overweight → Sector Weight
    Keybanc
    9/3/2021$150.00 → $156.00Outperform → Neutral
    Baird
    8/10/2021$130.00Buy → Neutral
    B of A Securities
    8/10/2021Buy → Neutral
    BofA Securities
    8/2/2021$131.00 → $145.00Overweight
    Keybanc
    More analyst ratings

    $HRC
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Hill-Rom Holdings downgraded by Morgan Stanley with a new price target

      Morgan Stanley downgraded Hill-Rom Holdings from Overweight to Equal-Weight and set a new price target of $156.00 from $148.00 previously

      9/20/21 5:05:49 AM ET
      $HRC
      Medical/Dental Instruments
      Health Care
    • Hill-Rom Holdings downgraded by Keybanc

      Keybanc downgraded Hill-Rom Holdings from Overweight to Sector Weight

      9/8/21 4:28:39 AM ET
      $HRC
      Medical/Dental Instruments
      Health Care
    • Hill-Rom Holdings downgraded by Baird with a new price target

      Baird downgraded Hill-Rom Holdings from Outperform to Neutral and set a new price target of $156.00 from $150.00 previously

      9/3/21 6:14:37 AM ET
      $HRC
      Medical/Dental Instruments
      Health Care

    $HRC
    Leadership Updates

    Live Leadership Updates

    See more
    • Amy Salzhauer And Greg Miller Join The Board Of ABM Respiratory Care

      SINGAPORE, Sept. 30, 2021 /PRNewswire/ -- ABM Respiratory Care, a medical technology company focused on developing and globally commercializing novel integrated airway clearance and ventilation solutions, announced today the appointment of Amy Salzhauer and Greg Miller to the company's Board of Directors.  Ms. Salzhauer currently serves as a Founder and Managing Partner at Good Growth Capital (GGC), an early-stage venture capital firm known for its exceptional expertise in finding, cultivating, and assessing complex science and technology start-ups based in Charleston, SC and Boston, MA.  Mr. Miller recently retired as Executive Vice President and Chief Information Officer of Genuine Parts C

      9/30/21 8:39:00 AM ET
      $GPC
      $HRC
      $NWL
      Automotive Aftermarket
      Consumer Discretionary
      Medical/Dental Instruments
      Health Care
    • Stacy Enxing Seng Joins the Vesper Medical Board of Directors

      WAYNE, Pa.--(BUSINESS WIRE)--Vesper Medical, Inc., a developer of medical devices for deep venous disease, today announced that Stacy Enxing Seng has joined the board of directors effective immediately. An accomplished executive leader, Stacy has over 25 years in sales, marketing and operational leadership roles building innovative technology portfolios, demonstrated clinical outcomes, exceptional management teams and world-class company cultures. She has been recognized as one of the Top 100 Women in Business and is a frequent speaker on healthcare, innovation leadership and corporate culture. She currently serves as a venture partner for Lightstone Ventures and since 2013 has a

      1/4/21 7:30:00 AM ET
      $LIVN
      $HRC
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
      Medical/Dental Instruments

    $HRC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more

    $HRC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form 4: Groetelaars John P returned 34,870 shares to the company, closing all direct ownership in the company

      4 - Hill-Rom Holdings, Inc. (0000047518) (Issuer)

      12/15/21 8:41:20 PM ET
      $HRC
      Medical/Dental Instruments
      Health Care
    • SEC Form 4: Frank Andreas G returned 16,539 shares to the company, closing all direct ownership in the company

      4 - Hill-Rom Holdings, Inc. (0000047518) (Issuer)

      12/15/21 8:41:21 PM ET
      $HRC
      Medical/Dental Instruments
      Health Care
    • SEC Form 4: Giertz James R returned 2,000 shares to the company, closing all direct ownership in the company

      4 - Hill-Rom Holdings, Inc. (0000047518) (Issuer)

      12/15/21 8:41:15 PM ET
      $HRC
      Medical/Dental Instruments
      Health Care
    • SEC Form SC 13G/A filed by Hill-Rom Holdings Inc (Amendment)

      SC 13G/A - Hill-Rom Holdings, Inc. (0000047518) (Subject)

      10/8/21 8:36:46 AM ET
      $HRC
      Medical/Dental Instruments
      Health Care
    • SEC Form SC 13G/A filed by Hill-Rom Holdings Inc (Amendment)

      SC 13G/A - Hill-Rom Holdings, Inc. (0000047518) (Subject)

      6/10/21 10:06:36 AM ET
      $HRC
      Medical/Dental Instruments
      Health Care
    • SEC Form SC 13G/A filed

      SC 13G/A - Hill-Rom Holdings, Inc. (0000047518) (Subject)

      2/10/21 10:57:20 AM ET
      $HRC
      Medical/Dental Instruments
      Health Care

    $HRC
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Alcoa Set to Join S&P MidCap 400

      NEW YORK, Dec. 13, 2021 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P MidCap 400: Alcoa Corp. (NYSE:AA) will replace Hill-Rom Holdings Inc. (NYSE:HRC) in the S&P MidCap 400 effective prior to the opening of trading on Monday, December 20. S&P 500 constituent Baxter International Inc. (NYSE:BAX) is acquiring Hill-Rom in a deal that was completed today. Following is a summary of the changes that will take place prior to the open of trading on the effective date: Effective Date Index Name       Action Company Name Ticker GICS Sector December 20, 2021 S&P MidCap 400 Addition Alcoa AA Materials S&P MidCap 400 Deletion Hill-Rom Holdings HRC Health Care For more

      12/13/21 7:20:00 PM ET
      $AA
      $BAX
      $HRC
      $SPGI
      Aluminum
      Industrials
      Medical/Dental Instruments
      Health Care
    • Hillrom Shareholders Approve Acquisition By Baxter

      CHICAGO, Dec. 2, 2021 /PRNewswire/ -- Hillrom (NYSE:HRC) today announced that its shareholders have voted to approve the previously announced pending acquisition by Baxter International Inc. (NYCE: BAX) at a special meeting. Hillrom shareholders voted overwhelmingly in favor of the transaction. Under the terms of the merger agreement, Hillrom shareholders will receive $156.00 per share in cash for every share of Hillrom stock they own immediately prior to the effective time of the merger. "The strong support of our investors over the years and in today's shareholder vote is an

      12/2/21 5:48:00 PM ET
      $BAX
      $HRC
      Medical/Dental Instruments
      Health Care
    • Hillrom Exceeds Fourth Quarter Guidance With Strong Finish To Fiscal Year

      CHICAGO, Nov. 5, 2021 /PRNewswire/ -- Hillrom (NYSE:HRC) today announced financial results for its fiscal fourth quarter and full-year ended September 30, 2021. For the fiscal fourth quarter, Hillrom reported GAAP earnings of $0.80 per diluted share, an increase of 27 percent compared to $0.63 per diluted share in the prior-year period. On an adjusted basis, excluding special items, earnings of $1.67 per diluted share increased 43 percent and exceeded the company's previously-issued guidance range of $1.44 to $1.48 per diluted share. Adjustments to reported earnings are detail

      11/5/21 6:59:00 AM ET
      $HRC
      Medical/Dental Instruments
      Health Care

    $HRC
    Financials

    Live finance-specific insights

    See more
    • Hillrom Exceeds Fourth Quarter Guidance With Strong Finish To Fiscal Year

      CHICAGO, Nov. 5, 2021 /PRNewswire/ -- Hillrom (NYSE:HRC) today announced financial results for its fiscal fourth quarter and full-year ended September 30, 2021. For the fiscal fourth quarter, Hillrom reported GAAP earnings of $0.80 per diluted share, an increase of 27 percent compared to $0.63 per diluted share in the prior-year period. On an adjusted basis, excluding special items, earnings of $1.67 per diluted share increased 43 percent and exceeded the company's previously-issued guidance range of $1.44 to $1.48 per diluted share. Adjustments to reported earnings are detail

      11/5/21 6:59:00 AM ET
      $HRC
      Medical/Dental Instruments
      Health Care
    • Hillrom Declares Quarterly Dividend

      CHICAGO, Nov. 2, 2021 /PRNewswire/ -- Hillrom (NYSE:HRC) announced today that its board of directors declared a quarterly dividend of $0.24 per share payable on December 31, 2021, to shareholders of record as of the close of business on December 15, 2021. The indicated annual dividend rate is $0.96 per share. About HillromHillrom is a global medical technology leader whose 10,000 employees have a single purpose: enhancing outcomes for patients and their caregivers by Advancing Connected Care™. Around the world, our innovations touch over 7 million patients each day. They help

      11/2/21 6:59:00 AM ET
      $HRC
      Medical/Dental Instruments
      Health Care
    • SV Health Investors Announces Three Realizations in its Growth Equity Portfolio

      BOSTON, Aug. 19, 2021 /PRNewswire/ -- SV Health Investors ("SV"), a leading global health care investment firm, is pleased to announce a series of realizations from its growth equity portfolio: On August 6, HillRom (NYSE:HRC) completed the acquisition of SV's portfolio company Bardy Diagnostics ("BDx"). In 2016, SV partnered with founder Dr. Gust Bardy to support the commercial launch of the Carnation Ambulatory Monitor, a best-in-class ambulatory cardiac monitor. The CAM offers both superior patient convenience and improved data capture. During the course of SV's partnership with BDx, the company built an increasingly sophisticated services capability and grew revenue ten-fold.  SV wishes t

      8/19/21 6:30:00 AM ET
      $BVS
      $HRC
      Medical/Dental Instruments
      Health Care

    $HRC
    SEC Filings

    See more
    • SEC Form 15-12B filed by Hill-Rom Holdings Inc

      15-12B - Hill-Rom Holdings, Inc. (0000047518) (Filer)

      12/23/21 9:20:51 AM ET
      $HRC
      Medical/Dental Instruments
      Health Care
    • SEC Form 10-K/A filed by Hill-Rom Holdings Inc (Amendment)

      10-K/A - Hill-Rom Holdings, Inc. (0000047518) (Filer)

      12/23/21 9:18:07 AM ET
      $HRC
      Medical/Dental Instruments
      Health Care
    • SEC Form S-8 POS filed by Hill-Rom Holdings Inc

      S-8 POS - Hill-Rom Holdings, Inc. (0000047518) (Filer)

      12/13/21 5:09:05 PM ET
      $HRC
      Medical/Dental Instruments
      Health Care